AI-Driven, Faster, Smarter Clinical Trials
Optimize trial design, uncover biomarkers, and make data-driven decisions with confidence. PhaseV’s AI/ML-powered platform enhances trial efficiency, reduces costs, and accelerates patient outcomes.

PhaseV Platform: Powering the Future of Clinical Development
AI and machine learning optimize every stage of clinical development—accelerating timelines, reducing costs, and improving patient outcomes with data-driven confidence.
Optimize Trial Design with AI-Powered Simulations
Run millions of simulations in minutes to refine clinical trial designs, improve efficiency, and maximize success rates.
- Accelerate trial timelines with optimized Bayesian, adaptive, and fixed trials
- Reduce patient burden and optimize sample sizes
- Make real-time adjustments with data-driven decision-making
- Designed for multi-stakeholder use be it clin ops, clinical development, biostats, or other stakeholders

Identify the Right Patients for the Right Treatment
Leverage AI to uncover treatment response patterns and identify high-potential patient subgroups for precision medicine.
- Detect heterogeneity even in complex biological data
- Improve patient stratification and trial efficiency
- Minimize false discoveries with rigorous AI validation

Uncover Biomarker Insights & Guide Treatment Strategy
Build AI-powered causal models to analyze biomarker correlations and drive smarter treatment decisions.
- Identify key biological drivers of disease progression
- Enhance indication selection with predictive insights
- Optimize treatment planning with real-world data models

Optimizing Trials Through Causal Machine Learning
PhaseV enhances clinical operations by applying causal machine learning across the trial lifecycle, from site selection to real-time monitoring.
- Identify sites aligned with the drug’s mechanism of action
- Maximize diversity and anticipate patient heterogeneity impacts.
- Track enrollment, progression, and dropouts with virtual control arms.

Additional Solutions for Smarter Clinical Development
Optimize trials, reduce costs, and accelerate drug development.
PhaseV Data
Lake
Leverage 300,000+ patient-level data across multiple therapeutic areas for deeper insights.
Causal ML for Site
Selection
Predict recruitment success and optimize trial site selection to reduce delays and costs.
Indication Selection & Expansion
Identify new indications and use cases for assets to guide life cycle management decisions.
Clinical Asset
Evaluation
Uncover hidden value in clinical assets and determine the probability of success to guide investment decisions.
Medical
Coder
Leverage 300,000+ patient-level data across multiple therapeutic areas for deeper insights.